Literature DB >> 15885255

Cholecystokinin and GABA interaction in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety.

Mehdi Rezayat1, Ali Roohbakhsh, Mohammad-Reza Zarrindast, Roohollah Massoudi, Bijan Djahanguiri.   

Abstract

In the present study, we have investigated the effects and interaction of CCK and GABAergic systems in the dorsal hippocampus of rats using the elevated plus-maze test of anxiety. Bilateral injection of different doses of CCK(8s) (0.01, 0.05 and 0.1 microg/rat) into the dorsal hippocampus (intra-CA1) decreased percentage of open arm time (%OAT) and open arm entries (%OAE) that are representative of anxiogenic-like behavior. The bilateral injection of three doses of LY225910, a selective CCK2 receptor antagonist (0.01, 0.1 and 0.5 microg/rat) produced significant anxiolytic behavior. Although muscimol (GABA(A+)) (0.1, 0.5 and 1 microg/rat, intra-CA1) produced dose dependent increase in %OAT and a slight increase in %OAE, bicuculline (GABA(A-)), (1, 2 and 4 microg/rat, intra-CA1) failed to change the anxiety profile. Both muscimol (0.1 microg/rat) and bicuculline (1 microg/rat), when co-administered with LY225910, reversed the effect of latter drug on anxiety but when co-administered with CCK8s (0.05 microg/rat) showed no effect on anxiety profile. In conclusion, it seems that both CCK and GABAergic systems not only play a part in the modulation of anxiety in the dorsal hippocampus of rats but also have demonstrated a complex interaction as well.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885255     DOI: 10.1016/j.physbeh.2005.03.002

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  18 in total

1.  Requirement of phospholipase C and protein kinase C in cholecystokinin-mediated facilitation of NMDA channel function and anxiety-like behavior.

Authors:  Zhaoyang Xiao; Manoj K Jaiswal; Pan-Yue Deng; Toshimitsu Matsui; Hee-Sup Shin; James E Porter; Saobo Lei
Journal:  Hippocampus       Date:  2011-11-10       Impact factor: 3.899

2.  GABA(A) ρ receptor mechanisms in the rat amygdala and its role in the modulation of fear and anxiety.

Authors:  Candy Flores-Gracia; Avril Nuche-Bricaire; Minerva Crespo-Ramírez; Ricardo Miledi; Kjell Fuxe; Miguel Pérez de la Mora
Journal:  Psychopharmacology (Berl)       Date:  2010-08-06       Impact factor: 4.530

3.  The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration.

Authors:  Agnieszka Nikiforuk; Tomasz Kos; Anna Wesołowska
Journal:  Psychopharmacology (Berl)       Date:  2011-04-16       Impact factor: 4.530

Review 4.  Anxiety, Depression, and the Microbiome: A Role for Gut Peptides.

Authors:  Gilliard Lach; Harriet Schellekens; Timothy G Dinan; John F Cryan
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

5.  Bidirectional modulation of GABAergic transmission by cholecystokinin in hippocampal dentate gyrus granule cells of juvenile rats.

Authors:  Pan-Yue Deng; Saobo Lei
Journal:  J Physiol       Date:  2006-02-02       Impact factor: 5.182

6.  Effects of 3 Hz and 60 Hz Extremely Low Frequency Electromagnetic Fields on Anxiety-Like Behaviors, Memory Retention of Passive Avoidance and Electrophysiological Properties of Male Rats.

Authors:  Amin Rostami; Minoo Shahani; Mohammad Reza Zarrindast; Saeed Semnanian; Mohammad Rahmati Roudsari; Mostafa Rezaei Tavirani; Hadi Hasanzadeh
Journal:  J Lasers Med Sci       Date:  2016-03-27

Review 7.  New Botanical Anxiolytics for Use in Companion Animals and Humans.

Authors:  Rui Liu; Fida Ahmed; Christian Cayer; Martha Mullally; Ana Francis Carballo; Marco Otarola Rojas; Mario Garcia; John Baker; Aleksandar Masic; Pablo E Sanchez; Luis Poveda; Zul Merali; Tony Durst; John T Arnason
Journal:  AAPS J       Date:  2017-09-11       Impact factor: 4.009

8.  Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of ΔFosB.

Authors:  Vincent Vialou; Rosemary C Bagot; Michael E Cahill; Deveroux Ferguson; Alfred J Robison; David M Dietz; Barbara Fallon; Michelle Mazei-Robison; Stacy M Ku; Eileen Harrigan; Catherine A Winstanley; Tej Joshi; Jian Feng; Olivier Berton; Eric J Nestler
Journal:  J Neurosci       Date:  2014-03-12       Impact factor: 6.167

Review 9.  Potential gut-brain mechanisms behind adverse mental health outcomes of bariatric surgery.

Authors:  Robyn M Brown; Eva Guerrero-Hreins; Wendy A Brown; Carel W le Roux; Priya Sumithran
Journal:  Nat Rev Endocrinol       Date:  2021-07-14       Impact factor: 43.330

10.  Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.

Authors:  Santiago J Ballaz; Michel Bourin; Huda Akil; Stanley J Watson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-09-14       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.